miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1

Correspondence: Cheng-Xiong Xu, Department of Molecular Oncology, Moffitt Cancer Center and Research Institute, Florida, USA. E-mail: xuchengxiong@hanmail.net ; Yan Wang, The General Hospital of Chinese People’s Liberation Army, Beijing, China.

http://ift.tt/1AAa9q7